NR5A2 and central nervous system cancer: Cisplatin chemosensitivity assay showed that forced expression of microRNA‐433‐3p in HS683/DDP cell line markedly promoted sensitivity of glioma cells to cisplatin, while NR5A2 could reverse the promotion of microRNA‐433‐3p on glioma cell sensitivity to cisplatin (Figure 4f).